Annual D&A
N/A
December 1, 2024
Summary
- ABBV annual depreciation & amortization is not available.
Performance
ABBV Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
N/A
December 1, 2024
Summary
- ABBV quarterly depreciation & amortization is not available.
Performance
ABBV Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
N/A
December 1, 2024
Summary
- ABBV TTM depreciation & amortization is not available.
Performance
ABBV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
ABBV Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
ABBV Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
AbbVie Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.08 B(-2.4%) | $8.36 B(-1.8%) |
| Jun 2024 | - | $2.13 B(+2.7%) | $8.52 B(-1.5%) |
| Mar 2024 | - | $2.07 B(-0.1%) | $8.64 B(-0.6%) |
| Dec 2023 | $8.70 B(+2.7%) | $2.08 B(-7.1%) | $8.70 B(-0.9%) |
| Sep 2023 | - | $2.23 B(-1.1%) | $8.78 B(+0.3%) |
| Jun 2023 | - | $2.26 B(+6.3%) | $8.75 B(+2.4%) |
| Mar 2023 | - | $2.13 B(-1.4%) | $8.54 B(+0.9%) |
| Dec 2022 | $8.47 B(-0.6%) | $2.16 B(-2.2%) | $8.47 B(+2.1%) |
| Sep 2022 | - | $2.21 B(+7.5%) | $8.29 B(+0.9%) |
| Jun 2022 | - | $2.05 B(-0.0%) | $8.21 B(-1.8%) |
| Mar 2022 | - | $2.05 B(+3.7%) | $8.36 B(-1.9%) |
| Dec 2021 | $8.52 B(+31.7%) | $1.98 B(-7.0%) | $8.52 B(-1.0%) |
| Sep 2021 | - | $2.13 B(-3.3%) | $8.61 B(-1.9%) |
| Jun 2021 | - | $2.20 B(-0.7%) | $8.77 B(+7.9%) |
| Mar 2021 | - | $2.21 B(+7.3%) | $8.13 B(+25.6%) |
| Dec 2020 | $6.47 B(+220.8%) | $2.06 B(-9.9%) | $6.47 B(+31.7%) |
| Sep 2020 | - | $2.29 B(+47.4%) | $4.92 B(+57.2%) |
| Jun 2020 | - | $1.55 B(+178.2%) | $3.13 B(+50.8%) |
| Mar 2020 | - | $559.00 M(+9.8%) | $2.07 B(+2.8%) |
| Dec 2019 | $2.02 B(+14.3%) | $509.00 M(+1.2%) | $2.02 B(+3.4%) |
| Sep 2019 | - | $503.00 M(+0.2%) | $1.95 B(+3.6%) |
| Jun 2019 | - | $502.00 M(-0.2%) | $1.88 B(+3.2%) |
| Mar 2019 | - | $503.00 M(+13.8%) | $1.82 B(+3.3%) |
| Dec 2018 | $1.76 B(+17.6%) | $442.00 M(+1.6%) | $1.76 B(+4.3%) |
| Sep 2018 | - | $435.00 M(-1.8%) | $1.69 B(+3.4%) |
| Jun 2018 | - | $443.00 M(-0.4%) | $1.64 B(+4.1%) |
| Mar 2018 | - | $445.00 M(+20.6%) | $1.57 B(+4.7%) |
| Dec 2017 | $1.50 B | $369.00 M(-2.6%) | $1.50 B(+2.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2017 | - | $379.00 M(0.0%) | $1.46 B(+5.4%) |
| Jun 2017 | - | $379.00 M(+1.3%) | $1.39 B(+6.9%) |
| Mar 2017 | - | $374.00 M(+14.0%) | $1.29 B(+8.9%) |
| Dec 2016 | $1.19 B(+42.2%) | $328.00 M(+7.9%) | $1.19 B(+6.0%) |
| Sep 2016 | - | $304.00 M(+5.2%) | $1.12 B(+7.4%) |
| Jun 2016 | - | $289.00 M(+7.8%) | $1.04 B(+10.5%) |
| Mar 2016 | - | $268.00 M(+2.7%) | $946.00 M(+13.2%) |
| Dec 2015 | $836.00 M(+6.4%) | $261.00 M(+15.0%) | $836.00 M(+8.9%) |
| Sep 2015 | - | $227.00 M(+19.5%) | $768.00 M(+4.8%) |
| Jun 2015 | - | $190.00 M(+20.3%) | $733.00 M(-1.6%) |
| Mar 2015 | - | $158.00 M(-18.1%) | $745.00 M(-5.2%) |
| Dec 2014 | $786.00 M(-12.4%) | $193.00 M(+0.5%) | $786.00 M(-0.9%) |
| Sep 2014 | - | $192.00 M(-5.0%) | $793.00 M(-5.0%) |
| Jun 2014 | - | $202.00 M(+1.5%) | $835.00 M(-3.9%) |
| Mar 2014 | - | $199.00 M(-0.5%) | $869.00 M(-3.1%) |
| Dec 2013 | $897.00 M(-22.0%) | $200.00 M(-14.5%) | $897.00 M(-10.8%) |
| Sep 2013 | - | $234.00 M(-0.8%) | $1.01 B(+0.7%) |
| Jun 2013 | - | $236.00 M(+4.0%) | $999.00 M(-5.6%) |
| Mar 2013 | - | $227.00 M(-26.5%) | $1.06 B(-8.0%) |
| Dec 2012 | $1.15 B(-9.6%) | $309.00 M(+36.1%) | $1.15 B(-1.3%) |
| Sep 2012 | - | $227.00 M(-23.1%) | $1.17 B(-7.0%) |
| Jun 2012 | - | $295.00 M(-7.5%) | $1.25 B(-1.8%) |
| Mar 2012 | - | $319.00 M(-1.8%) | $1.28 B(+0.4%) |
| Dec 2011 | $1.27 B(+7.4%) | $324.68 M(+3.0%) | $1.27 B(+34.3%) |
| Sep 2011 | - | $315.23 M(-0.7%) | $947.32 M(+49.9%) |
| Jun 2011 | - | $317.61 M(+1.0%) | $632.09 M(+101.0%) |
| Mar 2011 | - | $314.48 M | $314.48 M |
| Dec 2010 | $1.18 B(+69.8%) | - | - |
| Dec 2009 | $697.49 M | - | - |
FAQ
- What is the all time high annual D&A for AbbVie?
- What is the all time high quarterly D&A for AbbVie?
- What is the all time high TTM D&A for AbbVie?
What is the all time high annual D&A for AbbVie?
AbbVie all-time high annual depreciation & amortization is $8.70 B
What is the all time high quarterly D&A for AbbVie?
AbbVie all-time high quarterly depreciation & amortization is $2.29 B
What is the all time high TTM D&A for AbbVie?
AbbVie all-time high TTM depreciation & amortization is $8.78 B